Cargando…
Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms
BACKGROUND: Gene expression profiling has been used to define molecular phenotypes of complex diseases such as breast cancer. The luminal A and basal-like subtypes have been repeatedly identified and validated as the two main subtypes out of a total of five molecular subtypes of breast cancer. These...
Autores principales: | Sørlie, Therese, Wang, Yulei, Xiao, Chunlin, Johnsen, Hilde, Naume, Bjørn, Samaha, Raymond R, Børresen-Dale, Anne-Lise |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1489944/ https://www.ncbi.nlm.nih.gov/pubmed/16729877 http://dx.doi.org/10.1186/1471-2164-7-127 |
Ejemplares similares
-
Evaluation of MetriGenix custom 4D™ arrays applied for detection of breast cancer subtypes
por: Muggerud, Aslaug Aamodt, et al.
Publicado: (2006) -
Combining Gene Signatures Improves Prediction of Breast Cancer Survival
por: Zhao, Xi, et al.
Publicado: (2011) -
Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes
por: Nordgard, Silje H, et al.
Publicado: (2007) -
Merging transcriptomics and metabolomics - advances in breast cancer profiling
por: Borgan, Eldrid, et al.
Publicado: (2010) -
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma
por: Bjørklund, Sunniva Stordal, et al.
Publicado: (2017)